ID

22709

Descripción

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00619515

Link

https://clinicaltrials.gov/show/NCT00619515

Palabras clave

Versiones (1)
  1. 10/6/17 10/6/17 -
Subido en

10 de junio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00619515

Inglés

Eligibility Prostate Cancer NCT00619515

1 formularios  
Criteria
Descripción

Criteria

histologically confirmed adenocarcinoma of the prostate
Descripción

histologically confirmed adenocarcinoma of the prostate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0679557
UMLS CUI [1,2]
C0007112
disease confirmed by biopsy within 1 year of study entry
Descripción

disease confirmed by biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0750484
UMLS CUI [1,2]
C0007112
UMLS CUI [1,3]
C0194804
gleason score 2-7(3+4)
Descripción

gleason score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3203027
clinical stage t1a or t2b, n0 or nx, m0 or mx
Descripción

clinical tnm finding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707417
t- stage and n-stage determined by physical exam and available imaging studies (i.e., ultrasound, ct scan, and/or mri)
Descripción

t- stage and n-stage determined by physical exam and available imaging studies

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3258246
UMLS CUI [1,2]
C0475455
UMLS CUI [1,3]
C0456532
UMLS CUI [1,4]
C0031809
UMLS CUI [1,5]
C1881134
m-stage determined by physical exam, ct scan, and/or mri
Descripción

m-stage determined by physical exam, ct scan, and/or mri

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3258246
UMLS CUI [1,2]
C0449916
UMLS CUI [1,3]
C0031809
UMLS CUI [1,4]
C1881134
bone scan is not required unless clinical findings suggest possible osseous metastases
Descripción

bone scan is not required unless clinical findings suggest possible osseous metastases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0203668
UMLS CUI [1,2]
C0332147
UMLS CUI [1,3]
C0153690
psa ≤ 10 ng/ml within the past 60 days
Descripción

psa

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
at risk for recurrence, as defined by 1 of the following risk groups:
Descripción

at risk for recurrence

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1444641
UMLS CUI [1,2]
C0277556
low-risk, defined by the following combination:
Descripción

low risk recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3538919
UMLS CUI [1,2]
C0277556
stage t1a-t2a, gleason 2-6, and psa ≤ 10 ng/ml
Descripción

T stage, gleason score, psa

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0475455
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
low- to-intermediate-risk, defined by either of the following combinations:
Descripción

low- to-intermediate-risk recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3538919
UMLS CUI [1,2]
C3640764
UMLS CUI [1,3]
C0277556
stage t2b, gleason 2-6, and psa ≤ 10 ng/ml
Descripción

t stage, gleason score, psa

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0475455
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
stage t2b, gleason 3+4=7, and psa ≤ 10 ng/ml
Descripción

t stage, gleasons score, psa

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0475455
UMLS CUI [2]
C3203027
UMLS CUI [3]
C0201544
prostate volume must be ≤ 100 cc determined by measurement from ct scan or ultrasound within the past 90 days or within the past 14 days if hormone therapy is given
Descripción

prostate volume by measurement from ct scan or ultrasound, hormone therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1441416
UMLS CUI [1,2]
C0040405
UMLS CUI [1,3]
C0041618
UMLS CUI [2]
C0279025
patient characteristics:
Descripción

patient characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-1
Descripción

ecog

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
no implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
Descripción

no implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021102
UMLS CUI [1,2]
C0522473
UMLS CUI [1,3]
C2094182
UMLS CUI [1,4]
C2094475
prior concurrent therapy:
Descripción

prior concurrent therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205420
UMLS CUI [1,2]
C1514463
no prior definitive therapy for prostate cancer, including prostatectomy, cryotherapy, or radiotherapy to the prostate or lower pelvis
Descripción

prior therapy for prostate cancer, including prostatectomy, cryotherapy, or radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0600139
UMLS CUI [1,3]
C0033573
UMLS CUI [1,4]
C0010408
UMLS CUI [1,5]
C1522449
no more than 6 months of hormone ablation for gland downsizing
Descripción

hormone ablation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279492
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00619515

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
histologically confirmed adenocarcinoma of the prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0679557 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
disease confirmed by biopsy
Item
disease confirmed by biopsy within 1 year of study entry
boolean
C0750484 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
C0194804 (UMLS CUI [1,3])
gleason score
Item
gleason score 2-7(3+4)
boolean
C3203027 (UMLS CUI [1])
clinical tnm finding
Item
clinical stage t1a or t2b, n0 or nx, m0 or mx
boolean
C1707417 (UMLS CUI [1])
t- stage and n-stage determined by physical exam and available imaging studies
Item
t- stage and n-stage determined by physical exam and available imaging studies (i.e., ultrasound, ct scan, and/or mri)
boolean
C3258246 (UMLS CUI [1,1])
C0475455 (UMLS CUI [1,2])
C0456532 (UMLS CUI [1,3])
C0031809 (UMLS CUI [1,4])
C1881134 (UMLS CUI [1,5])
m-stage determined by physical exam, ct scan, and/or mri
Item
m-stage determined by physical exam, ct scan, and/or mri
boolean
C3258246 (UMLS CUI [1,1])
C0449916 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C1881134 (UMLS CUI [1,4])
bone scan is not required unless clinical findings suggest possible osseous metastases
Item
bone scan is not required unless clinical findings suggest possible osseous metastases
boolean
C0203668 (UMLS CUI [1,1])
C0332147 (UMLS CUI [1,2])
C0153690 (UMLS CUI [1,3])
psa
Item
psa ≤ 10 ng/ml within the past 60 days
boolean
C0201544 (UMLS CUI [1])
at risk for recurrence
Item
at risk for recurrence, as defined by 1 of the following risk groups:
boolean
C1444641 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
low risk recurrent disease
Item
low-risk, defined by the following combination:
boolean
C3538919 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
T stage, gleason score, psa
Item
stage t1a-t2a, gleason 2-6, and psa ≤ 10 ng/ml
boolean
C0475455 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
low- to-intermediate-risk recurrent disease
Item
low- to-intermediate-risk, defined by either of the following combinations:
boolean
C3538919 (UMLS CUI [1,1])
C3640764 (UMLS CUI [1,2])
C0277556 (UMLS CUI [1,3])
t stage, gleason score, psa
Item
stage t2b, gleason 2-6, and psa ≤ 10 ng/ml
boolean
C0475455 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
t stage, gleasons score, psa
Item
stage t2b, gleason 3+4=7, and psa ≤ 10 ng/ml
boolean
C0475455 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
prostate volume by measurement from ct scan or ultrasound, hormone therapy
Item
prostate volume must be ≤ 100 cc determined by measurement from ct scan or ultrasound within the past 90 days or within the past 14 days if hormone therapy is given
boolean
C1441416 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0041618 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2])
patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ecog
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
no implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery
Item
no implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
boolean
C0021102 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
C2094182 (UMLS CUI [1,3])
C2094475 (UMLS CUI [1,4])
prior concurrent therapy
Item
prior concurrent therapy:
boolean
C0205420 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
prior therapy for prostate cancer, including prostatectomy, cryotherapy, or radiotherapy
Item
no prior definitive therapy for prostate cancer, including prostatectomy, cryotherapy, or radiotherapy to the prostate or lower pelvis
boolean
C1514463 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0033573 (UMLS CUI [1,3])
C0010408 (UMLS CUI [1,4])
C1522449 (UMLS CUI [1,5])
hormone ablation
Item
no more than 6 months of hormone ablation for gland downsizing
boolean
C0279492 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial